Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Other Operating Expense : ¥660 Mil (TTM As of Mar. 2025)

View and export this data going back to 2009. Start your Free Trial

What is Shenzhenlubris Pharmaceuticals Co Other Operating Expense?

Shenzhenlubris Pharmaceuticals Co's Other Operating Expense for the three months ended in Mar. 2025 was ¥-1 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥660 Mil.

Shenzhenlubris Pharmaceuticals Co's quarterly Other Operating Expense increased from Sep. 2024 (¥-327 Mil) to Dec. 2024 (¥665 Mil) but then declined from Dec. 2024 (¥665 Mil) to Mar. 2025 (¥-1 Mil).

Shenzhenlubris Pharmaceuticals Co's annual Other Operating Expense increased from Dec. 2022 (¥524 Mil) to Dec. 2023 (¥546 Mil) and increased from Dec. 2023 (¥546 Mil) to Dec. 2024 (¥660 Mil).

Shenzhenlubris Pharmaceuticals Co Other Operating Expense Historical Data

The historical data trend for Shenzhenlubris Pharmaceuticals Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhenlubris Pharmaceuticals Co Other Operating Expense Chart

Shenzhenlubris Pharmaceuticals Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

540.71

656.97

523.88

545.85

660.37

Shenzhenlubris Pharmaceuticals Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															-0.85	322.97	-326.90	665.15	-1.33

Shenzhenlubris Pharmaceuticals Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥660 Mil.

Shenzhenlubris Pharmaceuticals Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Shenzhenlubris Pharmaceuticals Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhenlubris Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6009 Shennan Road, 37th Floor, Main Building, Chegongmiao Lvjing Plaza, Futian District, Guangdong, Shenzhen, CHN, 518040

Website

https://www.salubris.com

Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other countries and regions.

Executives

Yan Jie	Directors, executives
Yang Jian Feng	Secretary, Director
Zhao Song Ping	Executives
Liu Jun	Executives
Li Ai Zhen	Supervisors
Chen Ping	Executives
Ye Cheng Hai	Director
Lu Feng	Executives, directors
Chen Qiong Xing	Supervisors
Li Ying Hui	Supervisors
Pan Ling Man	Independent director
Zhang Zhong Xing	Executives

Shenzhenlubris Pharmaceuticals Co Headlines

No Headlines